Elisabetta Degasperi (Elisabetta De Gasperi)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Topics

African American

Hepatitis C Virus

Prognostic Factors

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Sexually transmitted infections

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics 59 (6) (2024)
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Advances in hepatitis delta research: emerging insights and future directions. Sexually transmitted infections (2024)
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Advances in hepatitis delta research: emerging insights and future directions. Sexually transmitted infections 100 (5) (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics 59 (6) (2024)
Maria Paola Anolli, Sara Colonia Uceda Renteria, Elisabetta Degasperi, Marta Borghi, Floriana Facchetti, Dana Sambarino, Riccardo Perbellini, Sara Monico, Ferruccio Ceriotti, Pietro Lampertico
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2024)
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Advances in hepatitis delta research: emerging insights and future directions. Sexually transmitted infections 100 (5) (2024)
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Advances in hepatitis delta research: emerging insights and future directions. Sexually transmitted infections 100 (5) (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics (2024)
Maria Paola Anolli, Sara Colonia Uceda Renteria, Elisabetta Degasperi, Marta Borghi, Floriana Facchetti, Dana Sambarino, Riccardo Perbellini, Sara Monico, Ferruccio Ceriotti, Pietro Lampertico
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods. Liver international : official journal of the International Association for the Study of the Liver (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics 59 (6) (2024)
Lisa Sandmann, Elisabetta Degasperi, Kerstin Port, Soo Aleman, Jeffrey J Wallin, Dmitry Manuilov, Ben L Da, Markus Cornberg, Pietro Lampertico, Benjamin Maasoumy, Heiner Wedemeyer, Katja Deterding
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Alimentary pharmacology & therapeutics 59 (6) (2024)
Maria Paola Anolli, Sara Colonia Uceda Renteria, Elisabetta Degasperi, Marta Borghi, Floriana Facchetti, Dana Sambarino, Riccardo Perbellini, Sara Monico, Ferruccio Ceriotti, Pietro Lampertico
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2024)
Elisa Farina, Alessandro Loglio, Giulia Tosetti, Elisabetta Degasperi, Mauro Viganò, Carmine Gentile, Sara Monico, Riccardo Perbellini, Marta Borghi, Floriana Facchetti, Sara Colonia Uceda Renteria, Ferruccio Ceriotti, Federica Cerini, Massimo Primignani, Pietro Lampertico
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years. Alimentary pharmacology & therapeutics (2023)
Alexander J Stockdale, Elisabetta Degasperi
HDV RNA and liver disease progression: What do we know? Hepatology (Baltimore, Md.) 79 (5) (2023)
Alexander J Stockdale, Elisabetta Degasperi
HDV RNA and liver disease progression: What do we know? Hepatology (Baltimore, Md.) (2023)
Alexander J Stockdale, Elisabetta Degasperi
HDV RNA and liver disease progression: What do we know? Hepatology (Baltimore, Md.) 79 (5) (2023)
Alexander J Stockdale, Elisabetta Degasperi
HDV RNA and liver disease progression: What do we know? Hepatology (Baltimore, Md.) (2023)
Elisabetta Degasperi, Maria P Anolli, Pietro Lampertico
Bulevirtide for patients with compensated chronic hepatitis delta: A review. Liver international : official journal of the International Association for the Study of the Liver (2022)
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies. Viruses 14 (11) (2022)
Antonio De Vincentis, Daphne D'Amato, Laura Cristoferi, Alessio Gerussi, Federica Malinverno, Ana Lleo, Francesca Colapietro, Fabio Marra, Andrea Galli, Cecilia Fiorini, Barbara Coco, Maurizia Rossana Brunetto, Grazia Anna Niro, Rosa Cotugno, Carlo Saitta, Raffaele Cozzolongo, Francesco Losito, Edoardo Giovanni Giannini, Sara Labanca, Marco Marzioni, Giulia Marconi, Anna Morgando, Rinaldo Pellicano, Ester Vanni, Nora Cazzagon, Annarosa Floreani, Luchino Chessa, Olivia Morelli, Luigi Muratori, Adriano Pellicelli, Maurizio Pompili, Francesca Romana Ponziani, Annalisa Tortora, Floriano Rosina, Maurizio Russello, Mariarita Cannavò, Loredana Simone, Silvia Storato, Mauro Viganò, Ludovico Abenavoli, Maria D'Antò, Elisabetta Degasperi, Marco Distefano, Gaetano Scifo, Teresa Zolfino, Vincenza Calvaruso, Giuseppe Cuccorese, Valeria Pace Palitti, Rodolfo Sacco, Gaetano Bertino, Evelise Frazzetto, Domenico Alvaro, Giacomo Mulinacci, Andrea Palermo, Miki Scaravaglio, Francesca Terracciani, Giovanni Galati, Vincenzo Ronca, Massimo Zuin, Ernesto Claar, Antonio Izzi, Antonio Picardi, Invernizzi Pietro, Umberto Vespasiani-Gentilucci, Marco Carbone, null null
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid. Liver international : official journal of the International Association for the Study of the Liver 42 (11) (2022)
Elisabetta Degasperi, Roberta D'Ambrosio, Pietro Lampertico
Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting antivirals in terms of prediction of hepatocellular carcinoma-authors' reply. Alimentary pharmacology & therapeutics 55 (1) (2022)
Irene Bergna, Elisabetta Degasperi, Roberta D'Ambrosio
Suboptimal accuracy of GES score to stratify post-SVR HCC risk in a single center cohort of European cirrhotics infected with any HCV genotype. Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2021)
Laura Cristoferi, Vincenza Calvaruso, Diletta Overi, Mauro Viganò, Cristina Rigamonti, Elisabetta Degasperi, Vincenzo Cardinale, Sara Labanca, Nicola Zucchini, Anna Fichera, Vito Di Marco, Monica Leutner, Rosanna Venere, Antonino Picciotto, Martina Lucà, Giacomo Mulinacci, Andrea Palermo, Alessio Gerussi, Daphne D'Amato, Sarah Elisabeth O'Donnell, Federica Cerini, Carla De Benedittis, Federica Malinverno, Vincenzo Ronca, Clara Mancuso, Nora Cazzagon, Antonio Ciaccio, Donatella Barisani, Marco Marzioni, Annarosa Floreani, Domenico Alvaro, Eugenio Gaudio, Pietro Invernizzi, Carpino Guido, Alessandra Nardi, Marco Carbone, null null
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach. Hepatology (Baltimore, Md.) 74 (3) (2021)
Massimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, Paolo Del Poggio, Paolo Perini, Roberta D'Ambrosio, Elisabetta Degasperi, Clara Dibenedetto, Alessia Giorgini, Luisa Pasulo, Franco Maggiolo, Francesco Castelli, Paola Brambilla, Ombretta Spinelli, Tiziana Re, Ana Lleo, Mariagrazia Rumi, Caterina Uberti-Foppa, Alessandro Soria, Alessio Aghemo, Pietro Lampertico, Chiara Baiguera, Monica Schiavini, Stefano Fagiuoli, Raffaele Bruno, null null
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting. Journal of viral hepatitis 28 (3) (2021)
Elisabetta Degasperi, Riccardo Perbellini, Roberta D'Ambrosio, Sara Colonia Uceda Renteria, Ferruccio Ceriotti, Alberto Perego, Corinna Orsini, Marta Borghi, Massimo Iavarone, Mariangela Bruccoleri, Alessandro Rimondi, Annalisa De Silvestri, Angelo Sangiovanni, Pietro Lampertico
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents. Alimentary pharmacology & therapeutics (2021)
Víctor Sapena, Marco Enea, Ferràn Torres, Ciro Celsa, Jose Ríos, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Mariño, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, Stefano Brillanti, Fabio Conti, Elisabetta Degasperi, Ming-Lung Yu, Pei-Chien Tsai, Kévin Jean, Mohamed El Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G Singal, Caitlin C Murphy, Mohamed Ahmed Samy Kohla, Chiara Masetti, Jean-François Dufour, Nicolás Merchante, Luisa Cavalletto, Liliana Lc Chemello, Stanislas Pol, Javier Crespo, Jose Luis Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Cammà, Jordi Bruix, Giuseppe Cabibbo, Maria Reig
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut (2021)
Luca Vittorio Valenti, Serena Pelusi, Alessio Aghemo, Sara Gritti, Luisa Pasulo, Cristiana Bianco, Claudia Iegri, Giuliana Cologni, Elisabetta Degasperi, Roberta D'Ambrosio, Paolo Del Poggio, Alessandro Soria, Massimo Puoti, Isabella Carderi, Marie Graciella Pigozzi, Canio Carriero, Angiola Spinetti, Valentina Zuccaro, Massimo Memoli, Alessia Giorgini, Mauro Viganò, Maria Grazia Rumi, Tiziana Re, Ombretta Spinelli, Maria Chiara Colombo, Tiziana Quirino, Barbara Menzaghi, Gianpaolo Lorini, Angelo Pan, Antonella D'Arminio Monforte, Elisabetta Buscarini, Aldo Autolitano, Paolo Bonfanti, Natalia Terreni, Gianpiero Aimo, Monia Mendeni, Daniele Prati, Pietro Lampertico, Massimo Colombo, Stefano Fagiuoli, null null
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study. Hepatology communications (2021)
Elisabetta Degasperi, Enrico Galmozzi, Serena Pelusi, Roberta D'Ambrosio, Roberta Soffredini, Marta Borghi, Riccardo Perbellini, Floriana Facchetti, Massimo Iavarone, Angelo Sangiovanni, Luca Vittorio Valenti, Pietro Lampertico
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs. Hepatology (Baltimore, Md.) 72 (6) (2020)
Elisabetta Degasperi, Enrico Galmozzi, Floriana Facchetti, Elisa Farina, Roberta D'Ambrosio, Roberta Soffredini, Massimo Iavarone, Pietro Lampertico
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals. Journal of viral hepatitis 26 (10) (2019)